Ani pharmaceuticals, inc. (ANIP) 2025Q4 financial report shows that the EPS surprise ratio has been above 5% for the past four quarters, meaning the company beat market expectations for earnings every quarter. This shows strong profit momentum and boosts market confidence. Usually, this reflects improved core competitiveness, stable industry demand, or a better product mix, all leading to better-than-expected profits. Continuous EPS surprises not only raise the company’s valuation but also attract capital and further lift the stock price. This kind of profit rhythm also encourages analysts to raise earnings forecasts and target prices, increasing capital market attention. You can also monitor revenue and net profit growth to see if the company continues to outperform the market.